Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 20, 2020 08:30 ET | Source: BioDelivery Sciences International

BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference

RALEIGH, N.C., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
November 11, 2020 08:30 ET | Source: BioDelivery Sciences International

BioDelivery Sciences to Present Virtually and Host 1x1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18

RALEIGH, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
November 05, 2020 08:00 ET | Source: BioDelivery Sciences International

BioDelivery Sciences Reports Strong Q3 2020 Results

Total Company Net Revenue Increased 30% versus Prior Year Reaching a Record $39.4 Million Conference Call and Webcast Scheduled for 8:30 AM EST Today RALEIGH, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE)...
November 04, 2020 17:31 ET | Source: BioDelivery Sciences International

BioDelivery Sciences Announces $25 Million Share Repurchase Program

RALEIGH, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
November 04, 2020 17:11 ET | Source: BioDelivery Sciences International

BioDelivery Sciences Announces Appointment of Jeff Bailey as Permanent CEO

RALEIGH, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
October 23, 2020 08:00 ET | Source: BioDelivery Sciences International

BioDelivery Sciences to Report Third Quarter 2020 Financial Results on November 5, 2020

RALEIGH, N.C., Oct. 23, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
September 11, 2020 08:00 ET | Source: BioDelivery Sciences International

BioDelivery Sciences Announces Five Scientific Poster Presentations at PAINWeek® 2020 National Conference on Pain Management

RALEIGH, N.C., Sept. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with...
September 03, 2020 08:00 ET | Source: BioDelivery Sciences International

BioDelivery Sciences to Present at Two Upcoming Investor Conferences

RALEIGH, N.C., Sept. 03, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with...
August 05, 2020 07:45 ET | Source: BioDelivery Sciences International

BioDelivery Sciences Reports Strong Q2 2020 Results

Second Quarter Total Company Net Revenue Increased 23% versus Prior Year to $36.6 Million Second Quarter BELBUCA® Net Sales Increased 34% versus Prior Year to $32.3 Million BELBUCA and Symproic®...
July 27, 2020 16:01 ET | Source: BioDelivery Sciences International

BioDelivery Sciences to Report Second Quarter 2020 Financial Results on August 5, 2020

RALEIGH, N.C., July 27, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...